Key result
An inhibition ELISA demonstrated high sensitivity (96.5%-100%) and specificity (92.7%-100%) for detecting anti-poliovirus types 1, 2, and 3 antibodies compared to the standard neutralization test.
Why the study?
Does an inhibition ELISA accurately detect neutralization-relevant antibodies against poliovirus compared to the neutralization test in vaccinated and naturally-infected populations?
Cross-Sectional (n=140)
Yes
Does an inhibition ELISA accurately detect neutralization-relevant antibodies against poliovirus compared to the neutralization test in vaccinated and naturally-infected populations?
The inhibition ELISA is a highly sensitive and specific tool for detecting poliovirus neutralizing antibodies without requiring live viruses or tissue cultures.
May support safer poliovirus serology without live virus; leaves open prospective validation before routine adoption.
To detect neutralization-relevant antibodies against 3 types of poliovirus (PV) without using tissue cultures and live viruses, an enzyme-linked immunosorbent assay (ELISA) based on monoclonal antibody-binding inhibition was evaluated using sera from 80 vaccinated Japanese children and 60 Pakistani poliomyelitis patients. Compared with the neutralization test, the sensitivity of the inhibition ELISA was 100% (111/111) for detection of anti-PV1 antibody, 98.3% (118/120) for anti-PV2, and 96.5% (82/85) for anti-PV3, and the specificity was 93.1% (27/29), 100% (20/20), and 92.7% (51/55), respectively. Thus, the inhibition ELISA showed excellent potential as a seroepidemiologic tool in both vaccinated and naturally-infected populations.
No takes yet. Share an insight, caveat, or question.
Hashido et al. (1999) conducted a cross-sectional in Poliovirus (n=140). Enzyme-linked immunosorbent assay (ELISA) based on monoclonal antibody-binding inhibition vs. Neutralization test was evaluated on Sensitivity and specificity for detection of anti-PV1, anti-PV2, and anti-PV3 antibodies. An inhibition ELISA demonstrated high sensitivity (96.5%-100%) and specificity (92.7%-100%) for detecting anti-poliovirus types 1, 2, and 3 antibodies compared to the standard neutralization test.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: